Advertisement
Screener

Carlsmed, Inc. (CARL) Shareholder Equity

Carlsmed, Inc. (CARL) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $204.27M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-17.00K.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $201.75M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
  • 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $199.67M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $198.85M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).

Carlsmed, Inc. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
USD
APIC, Share-based Payment Arrangement, Recognition and Exercise
USD
2026-06-30$0.00$0.00$204.27M$-17.00K$-120.01M$84.25M3 month · $2.27M(m)3 month · $11.00K
2026-03-31(m)$0.00$201.75M(m)$-109.50M$92.25M3 month · $1.63M(m)3 month · $10.00K
2025-12-31$0.00$0.00$199.67M$0.00$-100.81M$98.87M12 month · $1.93M12 month · $584.00K12 month · $42.00K
2025-09-30$0.00$0.00$198.85M(m)$-92.19M$106.66M3 month · $704.00K(m)3 month · $11.00K
2025-06-30(m)$0.00$593.00K(m)$-83.67M$-83.07M3 month · $258.00K(m)3 month · $10.00K
2025-03-31(m)(m)(m)(m)(m)$-76.61M3 month · $175.00K3 month · $584.00K3 month · $10.00K
2024-12-31$0.00$0.00$541.00K(m)$-71.17M$-70.63M12 month · $253.00K12 month · $592.00K12 month · $56.00K
2024-09-30(m)(m)(m)(m)(m)$-66.03M3 month · $66.00K3 month · $592.00K3 month · $45.00K
2024-06-30(m)(m)(m)(m)(m)$-57.74M3 month · $52.00K(m)(m)
2024-03-31(m)(m)(m)(m)(m)$-51.52M3 month · $35.00K(m)(m)
2023-12-31(m)(m)(m)(m)(m)$-46.13M(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orthofix Medical Inc. (OFIX)$0.373B
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
Embecta Corp. (EMBC)United States$0.319B2.10
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16